Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |